The Population Council is the leading developer of long-acting, reversible contraception. Council-developed products include the Copper T intrauterine device (IUD), the levonorgestrel intrauterine system Mirena®, and the implants Jadelle® and Norplant®. Currently 170 million women worldwide are using a Council-developed contraceptive.
We invest in contraceptive development from start to finish, ensuring that women have access to acceptable, effective methods that allow them to achieve their family planning goals.
The Council plays a unique role by employing a “bench to bedside” approach—whereby scientists identify drugs and delivery systems, conduct preclinical studies and late-stage clinical trials, and work with regulatory authorities to bring new technologies to the market. Our product pipeline includes vaginal rings and contraceptive gels. And we are pursuing new contraceptives for men that use the novel androgen MENT®, a synthetic steroid that resembles testosterone but does not stimulate prostate growth.